CLINICAL_TRIALS
trial_result
· 2026-06-26
Clinical Trial Results: A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated [Phase 1]
Summary
Phase 1 trial evaluating tolerability of different doses of BI 1569912 in healthy men; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2026-06-26